RE: Just a little more time.....I'm thinking top line numbers by the first part of Feb.
It gives the market some time to get a taste of what MCU can become.
There health care departmental investors can go over the numbers and talk to some of the cardiologist involved in the study.
I also would not be shock if Medicure goes back to the market for some more cash at 0.70 and we fall to 0.50 before the end of this year.....remember they are going back to the market for more cash to get them through to the phase III numbers. It would also be my belief that they already have an idea of where those numbers are going to land, so going back to the market is no big thing.
Remember they want to sell the company. Big Pharma has nothing but drugs that get launched and then the FDA takes the drug off the market...ie prexige/Novartis is the latest one....80 reps lost their jobs a few weeks ago over that one.
Medicure or MC-1 is a take over target. Medicure could sell MC-1 and keep the rest of the portfolio which will be a bigger market.
I would love to work for Medicure and launch this drug in Canada.